Vitamin D3 Does Not Improve Cardiovascular, Cancer Outcomes
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.